IDEAYA Biosciences
IDYA
117 hedge funds and large institutions have $822M invested in IDEAYA Biosciences in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 12 closing their positions.
96,914% more call options, than puts
Call options by funds: $6.79M | Put options by funds: $7K
93% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 28
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
21% more capital invested
Capital invested by funds: $677M → $822M (+$144M)
4% more funds holding
Funds holding: 112 → 117 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.22% less ownership
Funds ownership: 96.74% → 95.52% (-1.2%)
Top Buyers
| 1 |
BlackRock
New York
|
+$14.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.14M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.91M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.85M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$18.3M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$11.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.19M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.95M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.64M |
IDYA Hedge Fund Activity: Q4 2022 in Review
117 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2022, worth a combined $822M — up 21% from $677M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new IDYA positions and 12 closed out — a net gain of 6 holders — while 54 added to existing stakes and 28 trimmed.
The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was BVF Inc, cutting an estimated $18.3M.
- 117 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2022, up from 112 in Q3 2022.
- Funds reported $822M of IDEAYA Biosciences stock for Q4 2022, up 21% quarter-over-quarter.
- 18 funds opened new IDEAYA Biosciences positions in Q4 2022 and 12 closed out, a net change of +6 holders.
- The largest IDEAYA Biosciences buyer in Q4 2022 was BlackRock, an estimated $14.5M added.
- The largest IDEAYA Biosciences seller in Q4 2022 was BVF Inc, an estimated $18.3M sold.
Based on aggregated 13F filings for Q4 2022.